Oversight on Implementation of National Blood Policy, 1979 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Oversight on Implementation of National Blood Policy, 1979 PDF full book. Access full book title Oversight on Implementation of National Blood Policy, 1979 by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research. Download full books in PDF and EPUB format.
Author: United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research
Publisher:
ISBN:
Category : Blood
Languages : en
Pages : 136
Get Book Here
Book Description
Author: United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research
Publisher:
ISBN:
Category : Blood
Languages : en
Pages : 136
Get Book Here
Book Description
Author: United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research
Publisher:
ISBN:
Category : Blood
Languages : en
Pages : 0
Get Book Here
Book Description
"Almost 6 years ago the national blood policy was announced by the Secretary of Health, Education, and Welfare. It consists of four major goals: (1) To insure an adequate blood supply; (2) to provide the highest quality blood available; (3) to insure access to blood and blood products to everyone; and (4) to develop an efficient system of collection and distribution for blood. HEW went on to propose several objectives for the industry to meet these goals: (1) Recruitment of an all voluntary donor supply; (2) resource sharing on a regional basis; (3) development of a data information system for the blood banking industry; and (4) the identification of relationships between costs and charges"--Page 1.
Author: United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research
Publisher:
ISBN:
Category : Blood
Languages : en
Pages : 136
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 992
Get Book Here
Book Description
Author: United States. Superintendent of Documents
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1220
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1234
Get Book Here
Book Description
Author: Douglas Starr
Publisher: Knopf
ISBN: 0307823563
Category : Science
Languages : en
Pages : 628
Get Book Here
Book Description
Essence and emblem of life--feared, revered, mythologized, and used in magic and medicine from earliest times--human blood is now the center of a huge, secretive, and often dangerous worldwide commerce. It is a commerce whose impact upon humanity rivals that of any other business--millions of lives have been saved by blood and its various derivatives, and tens of thousands of lives have been lost. Douglas Starr tells how this came to be, in a sweeping history that ranges through the centuries. With the dawn of science, blood came to be seen as a component of human anatomy, capable of being isolated, studied, used. Starr describes the first documented transfusion: In the seventeenth century, one of Louis XIV's court physicians transfers the blood of a calf into a madman to "cure" him. At the turn of the twentieth century a young researcher in Vienna identifies the basic blood groups, taking the first step toward successful transfusion. Then a New York doctor finds a way to stop blood from clotting, thereby making all transfusion possible. In the 1930s, a Russian physician, in grisly improvisation, successfully uses cadaver blood to help living patients--and realizes that blood can be stored. The first blood bank is soon operating in Chicago. During World War II, researchers, driven by battlefield needs, break down blood into usable components that are more easily stored and transported. This "fractionation" process--accomplished by a Harvard team--produces a host of pharmaceuticals, setting the stage for the global marketplace to come. Plasma, precisely because it can be made into long-lasting drugs, is shipped and traded for profit; today it is a $5 billion business. The author recounts the tragic spread of AIDS through the distribution of contaminated blood products, and describes why and how related scandals have erupted around the world. Finally, he looks at the latest attempts to make artificial blood. Douglas Starr has written a groundbreaking book that tackles a subject of universal and urgent importance and explores the perils and promises that lie ahead.
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1174
Get Book Here
Book Description
First multi-year cumulation covers six years: 1965-70.
Author: United States. Congress. Senate. Library
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1166
Get Book Here
Book Description
Author: Committee to Study HIV Transmission Through Blood and Blood Products
Publisher: National Academies Press
ISBN: 0309588278
Category : Medical
Languages : en
Pages : 349
Get Book Here
Book Description
During the early years of the AIDS epidemic, thousands of Americans became infected with HIV through the nation's blood supply. Because little reliable information existed at the time AIDS first began showing up in hemophiliacs and in others who had received transfusions, experts disagreed about whether blood and blood products could transmit the disease. During this period of great uncertainty, decisionmaking regarding the blood supply became increasingly difficult and fraught with risk. This volume provides a balanced inquiry into the blood safety controversy, which involves private sexual practices, personal tragedy for the victims of HIV/AIDS, and public confidence in America's blood services system. The book focuses on critical decisions as information about the danger to the blood supply emerged. The committee draws conclusions about what was done--and recommends what should be done to produce better outcomes in the face of future threats to blood safety. The committee frames its analysis around four critical area Product treatment--Could effective methods for inactivating HIV in blood have been introduced sooner? Donor screening and referral--including a review of screening to exlude high-risk individuals. Regulations and recall of contaminated blood--analyzing decisions by federal agencies and the private sector. Risk communication--examining whether infections could have been averted by better communication of the risks.
